[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fxLN3MUwXCdr5RPjwZYIDpOj8CHyjOmngWTgoKXPtZbg":3,"$ftk0Ww6lGfmBUSjodJ3g2hxUWMGZDyAP9nWS3IbPpLtM":32,"$f3Ft0rKFJHppdzE-vuveecxx1BUcg9iOlMLtyzf_MJDg":157},[4,8,12,16,20,24,28],{"title":5,"slug":6,"path":7},"About Microbeonline.com","about-microbeonline-com","\u002Fabout-microbeonline-com\u002F",{"title":9,"slug":10,"path":11},"About Me","about-me","\u002Fabout-microbeonline-com\u002Fabout-me\u002F",{"title":13,"slug":14,"path":15},"Advertise with Us","advertise-us","\u002Fadvertise-us\u002F",{"title":17,"slug":18,"path":19},"Privacy Policy","privacy-policy","\u002Fprivacy-policy\u002F",{"title":21,"slug":22,"path":23},"Abbreviations","abbreviations","\u002Fabbreviations\u002F",{"title":25,"slug":26,"path":27},"Microbes","microbes","\u002Fmicrobes\u002F",{"title":29,"slug":30,"path":31},"Books","recommended-books","\u002Frecommended-books\u002F",{"type":33,"data":34},"blog",{"slug":35,"title":36,"description":37,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":40,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"body":44,"faq":45,"tags":46,"related":48},"neisseria-meningitidis-properties-pathogenesis-and-laboratory-diagnosis"," Neisseria meningitidis: Properties, Pathogenesis, Virulence Factors, and Lab Diagnosis","Neisseria meningitidis causes life-threatening bacterial meningitis and meningococcaemia. Learn its serogroups (A, B, C, W, X, Y), virulence factors (capsule, LOS, fimbriae, IgA protease), clinical features including petechial rash, lab diagnosis (CSF Gram stain, culture, PCR), and vaccines.",null,"Nisha Rijal","2020-07-12","2026-07-04",false,"bacteriology","A 19-year-old university student returns to her dormitory after a night out feeling unwell. She develops a headache and fever. By midnight she has a stiff neck. At 2 AM her roommate notices a rash spreading across her body — small red spots that do not blanch when a glass is pressed against them. She is taken to the emergency department. By the time she arrives, the rash has become large, purple, and confluent. She is in septic shock.\n\n*Neisseria meningitidis* serogroup B is confirmed from blood culture 48 hours later — but the clinical team did not wait for culture. They gave IV benzylpenicillin at the point of clinical recognition, before any diagnostic results. She survives with the loss of two fingertips to peripheral ischaemia.\n\nThis case illustrates the defining clinical feature of meningococcal disease: **speed.** From first symptoms to death, the interval can be less than 12 hours. The petechial rash of meningococcaemia is the most important physical sign in emergency medicine — a non-blanching rash in a febrile patient is meningococcaemia until proven otherwise and demands immediate treatment without waiting for results.\n\n*Neisseria meningitidis* (Nm), also referred to as meningococci are fastidious, aerobic Gram-negative diplococci with adjacent sides flattened (lens-shape\u002Fhalf-moon-shaped). It is a commensal of the nasopharynx for about 10% of immunocompetent individuals.\n\nMeningococci cause sepsis and life-threatening meningitis commonly referred to as invasive meningococcal disease (IMD) in susceptible individuals. Each year, approximately 1.2 million IMD cases have been reported worldwide, with the **African meningitis belt** reporting the highest incidence.\n\n![ - The African meningitis belt. These sub-Saharan countries are at high epidemic risk for meningococcal meningitis. (Image source: WHO)](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002FMeningitis-belt-of-Africa.jpg)Figure: The African meningitis belt. These sub-Saharan countries are at high epidemic risk for meningococcal meningitis. (Image source: WHO)\n\nMeningococcal-meningitis incidence rates are generally highest in children under five, followed by adolescents. IMD’s case fatality rate (CFR) ranges from 4.1% to 20%.\n\n![Gram stain of N. meningitidis in CSF - Gram stain ofN. meningitidisin CSF](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002FGram-stain-of-Neisseria-meningitidis-in-CSF.png)Figure: Gram stain of *N. meningitidis* in CSF\n\n## General Properties of Neisseria meningitidis\n\n1. Gram-negative intra-cellular diplococci\n2. *Neisseria meningitidis* (meningococcus) has a prominent polysaccharide capsule that enhances virulence through its complement inhibitory and antiphagocytic action. Nonencapsulated *N. meningitidis* isolates are generally considered nonpathogenic. The capsule is also the immunogen in the meningococcal vaccine.\n3. Serogroups: Based on the antigenic nature of capsular polysaccharides, *N. meningitidis* can be typed into 13 serogroups (A-D, X-Z, 29E, W135, H-J, and L). Six serogroups (types) of *Neisseria meningitidis* A, B, C, W, X, and Y cause the majority of cases of IMDs worldwide.\n\n![Distribution of Meningococcal serogroups in the world - Distribution of Meningococcal serogroups in the world](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002FIncidence-of-Meningococcal-Serogroups.jpg)Figure: Distribution of Meningococcal serogroups in the world\n\nSerotype A was the leading cause of epidemic meningitis worldwide, mainly in the African meningitis belt. However, its incidence decreased after the i**ntroduction of group A meningococcal polysaccharide–tetanus toxoid conjugate vaccine (PsA-TT; MenAfriVac) in Africa in 2010.**\n\n## Pathogenesis\n\n**Transmission**\n\n*Neisseria meningitidis* lives as normal upper respiratory tract flora in young adults. Carriage is highest in adolescents and young adults (approx 10%), mostly due to their lifestyle. Carriage rates are generally lower in older adults and infants.\n\nThe bacteria are transmitted from person to person through carriers’ droplets of respiratory or throat secretions. Smoking, close and prolonged contact (such as kissing, sneezing, or coughing), or living in close quarters with a carrier facilitates the spread of the disease. The reasons for transitioning from asymptomatic carriage to invasive disease are not completely understood.\n\n## Virulence Factors of Neisseria meningitidis\n\n![Surface proteins of Neisseria meningitidis. Source: Sciencedirect.com - Surface proteins ofNeisseria meningitidis. Source: Sciencedirect.com](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002Fsurface-proteins-of-neisseria-meningitidis-300x247.jpg)Figure: Surface proteins of *Neisseria meningitidis*. Source: Sciencedirect.com\n\n### 1. Polysaccharide Capsule — Primary Virulence Factor\n\nThe polysaccharide capsule is the most important virulence determinant of *N. meningitidis*:\n\n- **Antiphagocytic** — inhibits complement-mediated opsonisation and phagocytosis by neutrophils and macrophages\n- **Complement inhibition** — capsular polysaccharides interfere with C3b deposition, preventing complement-mediated killing\n- **Basis of serogroup classification** — 13 serogroups defined by capsular polysaccharide antigenicity; 6 serogroups (A, B, C, W, X, Y) cause >90% of disease\n- **Vaccine immunogen** — capsular polysaccharides are the antigens in all licensed meningococcal vaccines (MenACWY conjugate; MenB protein-based)\n\n> Non-encapsulated *N. meningitidis* strains are generally considered non-pathogenic — the capsule is essential for invasive disease. However, non-encapsulated strains can colonise the nasopharynx asymptomatically.\n\n### 2. Lipooligosaccharide (LOS)\n\nAs with *N. gonorrhoeae*, *N. meningitidis* produces LOS rather than full LPS:\n\n- **Carbohydrate lacto-N-neotetraose** — a major meningococcal virulence determinant; mimics host cell surface oligosaccharides\n- **Stimulates TNF-α release** — the endotoxin activity of LOS drives the cytokine storm responsible for the rapid circulatory collapse in meningococcaemia\n- **DIC trigger** — LOS-induced inflammation activates coagulation cascades → disseminated intravascular coagulation → petechial rash\n\n### 3. Fimbriae (Pili)\n\nMeningococcal pili mediate:\n\n- Initial attachment to nasopharyngeal epithelial cells\n- Microcolony formation facilitating mucosal colonisation\n- Phase and antigenic variation — similar to gonococcal pili; contributes to immune evasion during carriage\n\n### 4. IgA1 Protease\n\nAll meningococci produce IgA1 protease — identical function to the gonococcal enzyme:\n\n- Cleaves secretory IgA1 at the hinge region\n- Destroys mucosal antibody blocking nasopharyngeal attachment\n- Antibodies against IgA1 protease are produced during both carriage and disease — a potential vaccine target\n\n### 5. Outer Membrane Proteins — PorA and PorB\n\nMeningococcal porins have dual roles:\n\n- **PorA** — major outer membrane protein; highly variable; target for protein-based MenB vaccines\n- **PorB** — serum resistance; inhibits complement deposition; contributes to resistance to killing in the bloodstream\n\n### 6. Factor H Binding Protein (fHbp)\n\n*N. meningitidis* expresses a surface protein that binds human complement regulator Factor H:\n\n- Binding Factor H to the bacterial surface prevents complement activation and C3b deposition\n- Highly immunogenic and is a key component of protein-based MenB vaccines (Bexsero, Trumenba)\n- Represents a rational vaccine target — blocking fHbp would remove complement protection from the bacterium\n\n### Virulence Factor Summary\n\n| Virulence factor | Function | Clinical relevance |\n| --- | --- | --- |\n| Capsule | Antiphagocytic; complement inhibition | Essential for invasive disease; vaccine target |\n| LOS | Endotoxin; TNF-α induction; DIC trigger | Drives the rapid circulatory collapse in septicaemia |\n| Pili | Mucosal attachment; microcolony formation | Colonisation and transmission |\n| IgA1 protease | Destroys mucosal IgA | Enables nasopharyngeal colonisation |\n| PorA\u002FPorB | Serum resistance; complement evasion | Allows survival in bloodstream |\n| fHbp | Factor H binding; complement evasion | Vaccine target (MenB vaccines) |\n\n## Clinical Manifestations\n\nThe two main clinical manifestations of invasive meningococcal disease are meningitis (75% – 80%) and septicemia (15% – 20%). Occasionally, meningococci cause other infections, including pneumonia, pericarditis, conjunctivitis, endophthalmitis, septic arthritis, pelvic disease, or chronic low-grade septicemia.\n\n**Meningococcal meningitis**\n\nMeningococcal meningitis is a serious infection of the meninges that affects the brain membrane. The liberation of endotoxin (by the bacteria) into the subarachnoid space provokes a marked cytokine-mediated inflammation of the meninges. Early symptoms are fever, malaise, nausea, shivers, tachycardia, and mild headache. As the illness progresses, headache may become more pronounced, accompanied by photophobia, confusion, and vomiting (due to raised intracranial pressure), followed by coma if untreated. In newborns and babies, symptoms such as being slow or inactive, irritable, vomiting, feeding poorly, or the presence of a bulging in the soft spot of the skull (anterior fontanelle) may be an indication rather than the classic symptoms.\n\n**Septicemia**\n\nA less common but even more severe (often fatal) form of meningococcal disease is meningococcal septicemia, characterized by a hemorrhagic rash and rapid circulatory collapse. Most patients become progressively ill within 24 to 48 hours. However, in a few cases, the disease progresses so rapidly that the patient becomes moribund or dies within a few hours of the onset of infection.\n\n### Waterhouse-Friderichsen Syndrome\n\nThe most severe form of meningococcal septicaemia is Waterhouse-Friderichsen syndrome — bilateral adrenal haemorrhage occurring as a complication of overwhelming meningococcaemia:\n\n- **Mechanism:** Severe DIC and LOS-driven endothelial damage cause haemorrhage into both adrenal glands → acute adrenocortical insufficiency → cardiovascular collapse\n- **Features:** Purpuric rash (rapidly progressing from petechiae to large confluent purpura), hypotension unresponsive to fluids, high fever or hypothermia, shock\n- **Mortality:** Extremely high without immediate treatment; historically approached 100% without antibiotics and supportive care\n- **Recognition:** The glass test — pressing a glass firmly against petechial spots; if spots do not blanch (disappear when compressed) → non-blanching rash → meningococcaemia until proven otherwise → immediate medical emergency\n\n## Meningococcal Vaccines\n\nVaccines are the most effective tool for prevention of invasive meningococcal disease:\n\n| Vaccine type | Covers | Examples | Notes |\n| --- | --- | --- | --- |\n| **Polysaccharide–protein conjugate** | Serogroups A, C, W, Y | MenACWY (Menveo, Nimenrix) | Conjugation to protein carrier gives T-cell dependent response; better immunogenicity in young children |\n| **Protein-based (serogroup B)** | Serogroup B | Bexsero (4CMenB), Trumenba (MenB-FHbp) | Uses PorA, fHbp, NHBA, NadA proteins; serogroup B capsule is identical to human neural cell adhesion molecule — cannot be used as vaccine antigen |\n| **Polysaccharide (older, non-conjugate)** | A, C, W, Y | Menomune | Less immunogenic; not T-cell dependent; poor response <2 years; being replaced by conjugate vaccines |\n\n> **Why serogroup B vaccine is different:** Serogroup B capsular polysaccharide is identical to polysialic acid found on human neural cell adhesion molecules — it is self-antigen and cannot safely be used as a vaccine immunogen. Serogroup B vaccines instead use conserved outer membrane proteins (PorA, fHbp, NHBA, NadA), which is why they are protein-based rather than polysaccharide-based.\n\n## Laboratory Diagnosis\n\n### Sample\n\nCerebrospinal fluid (CSF), blood and skin scrapings from petechial rashes from cases, and nasopharyngeal swabs from carriers. Specimens should be collected in sterile containers and transported immediately without any delay.\n\n> CSF should never be refrigerated as suspected agents of meningitis (pneumococci, meningococci, and Haemophilus influenzae) are delicate and may die on refrigeration).\n\n### Gram Stain\n\nIn Gram-stained smear of centrifuged deposit of specimen (CSF or sterile body fluid), *N. meningitidis* appear as Gram-negative, coffee-bean-shaped diplococci occurring intracellularly or extracellularly in PMN leukocytes.\n\n### Culture\n\nIsolation of *N. meningitidis* (from blood, CSF, or other normally sterile sites) remains the gold standard as it also provides isolates for strain differentiation and susceptibility testing.\n\nSince meningococci are fastidious, samples from sterile body sites are inoculated on either blood or chocolate agar. The chocolate agar base can be enriched with antibiotics such as vancomycin, colistin, nystatin, and trimethoprim for selective isolation of *N. meningitidis*. For culture from non-sterile sites such as the nasopharynx, a selective media such as Modified New York City or Modified Thayer Martin medium are required. Culture plates should be incubated for a minimum of 48 hours with a source of 5% CO2.\n\n![Neisseria meningitidis in Blood Agar - Neisseria meningitidisin Blood Agar](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002FNeisseria-meningitidis-in-Blood-Agar-Plate.png)Figure: *Neisseria meningitidis* in Blood Agar\n\nOn Blood agar, young colonies of *N. meningitidis* are round, smooth, moist, glistening, and convex, with a clearly defined edge whereas actively growing colonies are grey and unpigmented. Older cultures (> 24 hours) become more opaquely grey and sometimes cause the underlying agar to turn dark.\n\nOn Modified New York City medium and Thayer Martin medium, *Neisseria meningitidis* appears as large colorless to bluish-gray mucoid colonies.\n\n### Identification\n\nBiochemical tests for the Identification of *Neisseria meningitidis:*\n\n- Catalase Positive\n- Oxidase positive.\n- Produce acid from glucose and maltose but not from lactose or sucrose.\n- Nitrate Reduction Test: negative\n- Produce gamma-glutamyl aminopeptidase\n- Resistant to colistin: meningococci are colistin-resistant and grow on selective media containing VCN inhibitor\n- DNAse reaction: negative\n- Superoxol Test (reaction with 30% hydrogen peroxide): may show weak to a strong reaction.\n- Pigmentation: produce pink-brown pigments.\n\n### Sero-grouping\n\nVarious serogroups of *N.meningitidis* are differentiated by slide agglutination test using monovalent antisera.\n\n### Serological tests\n\nSeveral serological tests, such as enzyme immunoassay, latex agglutination, and rapid diagnostic tests, are available to detect antibodies against capsular antigens of *Neisseria meningitidis*. Serological tests help in the retrospective diagnosis of disease. Antibodies are also seen when vaccination is successful and in cases of chronic meningococcemia.\n\n### Molecular diagnosis\n\nPCR-based diagnosis provides confirmation of meningococcal disease from blood, CSF, or other normally sterile sites with a validity comparable to that of culture-based diagnosis.\n\n## How to Remember\n\n**The clinical emergency rule:** Non-blanching rash + fever = meningococcaemia until proven otherwise. Do not wait for results. Do not wait for a lumbar puncture. Give IV benzylpenicillin immediately if meningococcal disease is suspected clinically.\n\n**The six serogroups — A B C W X Y:** **A**frica (meningitis belt) **B** in Britain\u002FEurope (hardest to vaccinate — identical to human self-antigen) **C** in Collegiate outbreaks (university students) **W** at Worldwide events (Hajj outbreaks) **X** in Africa (emerging) **Y** in Younger adults and elderly (USA)\n\n**Capsule = key distinguisher from gonococcus:** Meningococcus HAS capsule → serogroups → vaccine possible Gonococcus has NO capsule → antigenic variation of pili instead → no effective vaccine\n\n**The DIC cascade:** LOS → TNF-α → endothelial damage → DIC → petechiae → purpura → adrenal haemorrhage (Waterhouse-Friderichsen) → cardiovascular collapse Each step explains the next — the rash is not the infection, it is the body's inflammatory response to LOS destroying the vascular endothelium.\n\n**Why CSF should never be refrigerated:** Meningococcus, pneumococcus, and *H. influenzae* — the three classic causes of bacterial meningitis — are all fastidious and cold-sensitive. Refrigerating CSF kills the organisms before culture. Transport immediately to the lab at room temperature or in an incubator at 37°C.\n\n**References and Further Readings**\n\n1. Tille, P. M. (2017). *Bailey and Scott's Diagnostic Microbiology* (14th ed.). Elsevier.\n2. Tzeng, Y. L., & Stephens, D. S. (2000). Epidemiology and pathogenesis of *Neisseria meningitidis*. *Microbes and Infection*, 2(6), 687–700. \u003Chttps:\u002F\u002Fdoi.org\u002F10.1016\u002FS1286-4579(00)00356-2>\n3. Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Popovic, T., & Hughes, J. M. (2001). Meningococcal disease. *New England Journal of Medicine*, 344(18), 1378–1388. \u003Chttps:\u002F\u002Fdoi.org\u002F10.1056\u002FNEJM200105033441807>\n4. Jolley, K. A., Maiden, M. C. J., & Feavers, I. M. (2007). Molecular typing and global epidemiology of *Neisseria meningitidis*. *FEMS Microbiology Reviews*, 31(2), 175–191. \u003Chttps:\u002F\u002Fdoi.org\u002F10.1111\u002Fj.1574-6976.2006.00060.x>\n5. World Health Organization. (2011). Meningococcal vaccines: WHO position paper. *Weekly Epidemiological Record*, 86(47), 521–540.\n6. Vipond, C., Wheeler, J. X., Jones, C., Feavers, I. M., & Suker, J. (2005). Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry. *Human Vaccines*, 1(2), 80–84.",[],[47],"gram-negative-cocci",[49,77,94,103,110,126,133,151],{"slug":50,"title":51,"description":52,"seoTitle":38,"seoDescription":38,"author":53,"createdDate":54,"lastUpdatedDate":55,"draft":42,"category":56,"image":38,"faq":57,"tags":76},"rapid-carbohydrate-utilization-test-rcut","RCUT for Neisseria: The Maltose Result That Separates Gonorrhoeae from Meningitidis","Neisseria gonorrhoeae and N. meningitidis look identical under the microscope, but one uses glucose only and the other uses glucose and maltose. RCUT reads that sugar panel in 4 hours, without the false negatives that plagued the old CTA method. Here is the maltose rule, why the test must stay out of a CO2 incubator, and the traps that cause misidentification.","Acharya Tankeshwar","2019-12-11","2026-07-12","biochemical-tests",[58,61,64,67,70,73],{"question":59,"answer":60},"Why is maltose the key sugar in identifying Neisseria?","Because maltose separates the two pathogenic Neisseria that look identical under the microscope. Neisseria gonorrhoeae uses glucose only, while Neisseria meningitidis uses both glucose and maltose. Since glucose is positive for both, it tells you nothing on its own; the maltose result is the discriminator. A memory aid: the M in meningitidis matches the M in maltose. This single result changes the diagnosis from a sexually transmitted infection to a cause of meningitis, along with the treatment and public-health response.",{"question":62,"answer":63},"Why must RCUT not be incubated in a CO2 incubator?","Because dissolved carbon dioxide forms carbonic acid, which turns the phenol red indicator yellow even when the organism has not used any carbohydrate. This produces a false-positive acid reaction in every tube. Although Neisseria are grown in a CO2 atmosphere for primary isolation, the RCUT tubes are incubated in a plain aerobic incubator or water bath at 35 degrees. Grow the organism in CO2, but test it out of CO2.",{"question":65,"answer":66},"Why did RCUT replace the older CTA sugar test?","Because CTA was slow and prone to false negatives. Neisseria produce acid oxidatively rather than fermentatively, so they make very little acid, and the peptone in CTA generates alkaline ammonia that can neutralize that small amount of acid, hiding a true positive. CTA also took 24 to 72 hours. RCUT uses a peptone-free, buffered saline so the weak acid registers, and it gives results in about 4 hours.",{"question":68,"answer":69},"What does it mean if all RCUT sugars stay red?","An organism that produces no acid from any sugar is asaccharolytic. Among the oxidase-positive Gram-negative diplococci, Moraxella catarrhalis is the classic asaccharolytic organism, staying red across glucose, maltose, lactose, and sucrose. It is confirmed with additional tests such as DNase and butyrate esterase. Note that some Neisseria, like N. cinerea, can also appear negative because they over-oxidize the acid to carbon dioxide before it accumulates.",{"question":71,"answer":72},"How is Neisseria lactamica distinguished from Neisseria meningitidis?","By lactose. Both use glucose and maltose, but only Neisseria lactamica also uses lactose, giving a positive lactose result (or a positive ONPG test). N. lactamica is a non-pathogenic commensal of the throat that can otherwise be mistaken for meningococcus, so the lactose or ONPG result is an important safeguard against misidentification.",{"question":74,"answer":75},"Why can contaminated maltose cause a Neisseria misidentification?","Because maltose from some suppliers is contaminated with free glucose. Since Neisseria gonorrhoeae uses glucose, glucose-contaminated maltose can make a gonorrhoeae isolate appear maltose-positive, which would mimic Neisseria meningitidis. Because maltose is the critical result separating those two organisms, this contamination directly causes a wrong identification. Using reagent-grade maltose prevents it.",[47],{"slug":78,"title":79,"description":80,"seoTitle":38,"seoDescription":38,"author":53,"createdDate":81,"lastUpdatedDate":41,"draft":42,"category":82,"image":38,"faq":83,"tags":93},"thayer-martin-agar-composition-preparation-uses-colony-characteristics","Thayer-Martin Agar (Modified): Composition, Principle, Uses, and Colony Characteristics of Neisseria","Modified Thayer-Martin (MTM) agar is the standard selective medium for isolating Neisseria gonorrhoeae from genital specimens. Learn its VCNT antibiotic selectivity, GC agar base composition, colony types, and how it compares to NYC medium and Martin-Lewis agar.","2016-06-13","culture-media",[84,87,90],{"question":85,"answer":86},"Why does Neisseria gonorrhoeae survive colistin in Thayer-Martin agar when most Gram-negative organisms do not?","Colistin (polymyxin E) kills most Gram-negative bacteria by disrupting the outer membrane through binding to lipopolysaccharide (LPS) and displacing calcium and magnesium ions that stabilise the membrane. Neisseria gonorrhoeae has inherent resistance to colistin due to specific modifications in the lipid A component of its LPS — particularly the addition of phosphoethanolamine groups that reduce the net negative charge of the outer membrane surface and decrease colistin binding affinity. These same outer membrane modifications are present in N. meningitidis, explaining why both pathogenic Neisseria species survive in colistin-containing selective media while most other Gram-negative organisms are inhibited.",{"question":88,"answer":89},"What is the significance of T1 and T2 versus T3 and T4 colony types of N. gonorrhoeae, and why does it matter clinically?","N. gonorrhoeae colonies are classified into four types (T1–T4) based on the presence and density of type IV pili on the cell surface. T1 and T2 colonies are small, raised, and glistening — produced by piliated organisms. Pili are major virulence factors that enable the organism to adhere to epithelial cells in the urogenital tract, resist phagocytosis, and initiate infection. T3 and T4 colonies are larger and flatter — produced by non-piliated variants that emerge after repeated subculture in the laboratory. Non-piliated gonococci are avirulent in animal models and cannot efficiently colonise human mucosa. The clinical significance is twofold: (1) fresh clinical isolates should produce T1\u002FT2 colonies, confirming their virulence; and (2) for antibiotic susceptibility testing and research work, only first- or second-passage cultures should be used, because repeated subculture produces T3\u002FT4 non-piliated variants that do not represent the clinical isolate.",{"question":91,"answer":92},"Why must N. gonorrhoeae specimens be inoculated onto Thayer-Martin agar immediately, and what happens if there is a delay?","N. gonorrhoeae has extreme sensitivity to three environmental stresses that make delay fatal: (1) desiccation — the organism dies within minutes on a dry swab due to its lack of protective structures and high membrane permeability; (2) cold temperature — below 35°C, the organism's membrane lipid composition shifts in a way that impairs metabolism and viability; and (3) pH change — metabolic activity of other organisms on the swab produces acid that kills gonococci within hours. In practice, for each hour of delay at room temperature on a plain swab, recovery rates fall significantly. The recommended approach is direct inoculation at the point of collection, with immediate placement into a CO2-enriched environment (CO2 incubator, candle jar, or JEMBEC transport system with CO2-generating tablet). JEMBEC plates — MTM agar in a sealed plastic bag with a CO2-generating sodium bicarbonate tablet — were developed specifically to maintain CO2 levels and temperature during transport, allowing up to 24–48 hour transport with acceptable recovery.",[47],{"slug":95,"title":96,"description":97,"seoTitle":38,"seoDescription":38,"author":53,"createdDate":98,"lastUpdatedDate":99,"draft":42,"category":43,"image":38,"faq":100,"tags":101},"gram-negative-cocci-coccobacilli-medical-significance-list-bacteria-diseases","Gram-Negative Cocci and Coccobacilli of Medical Significance: List, Diseases, and Lab Identification","The medically important Gram-negative cocci include Neisseria gonorrhoeae (gonorrhoea, ophthalmia neonatorum), N. meningitidis (meningitis), and Moraxella catarrhalis (otitis media, COPD). This hub covers all GN cocci and coccobacilli with diseases, key properties, and lab identification links.","2016-04-11","2026-07-18",[],[47,102],"bacterial-classification",{"slug":104,"title":105,"description":106,"seoTitle":38,"seoDescription":38,"author":53,"createdDate":107,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"faq":108,"tags":109},"differences-neisseria-gonorrhoeae-neisseria-meningitides","Differences between Neisseria gonorrhoeae and Neisseria meningitidis: A Complete Comparison","N. gonorrhoeae and N. meningitidis are both Gram-negative diplococci but differ fundamentally in capsule, diseases, transmission, maltose fermentation, serogroups, vaccine availability, and treatment. This complete comparison table covers all key distinguishing features for lab identification and clinical practice.","2015-11-24",[],[47],{"slug":111,"title":112,"description":113,"seoTitle":38,"seoDescription":38,"author":53,"createdDate":114,"lastUpdatedDate":41,"draft":42,"category":82,"image":38,"faq":115,"tags":125},"new-york-city-medium-agar-introduction-principle-composition-uses","New York City (NYC) Medium: Composition, Principle, Uses, and Colony Characteristics","New York City (NYC) medium is a selective medium for Neisseria gonorrhoeae that uniquely supports genital Mycoplasma and Ureaplasma alongside Neisseria. Learn its principle, horse plasma role, colony characteristics, and how it differs from Modified Thayer-Martin agar.","2014-01-26",[116,119,122],{"question":117,"answer":118},"Why does NYC medium support Mycoplasma and Ureaplasma growth when Modified Thayer-Martin agar does not?","Mycoplasma hominis and Ureaplasma urealyticum are cell wall-deficient organisms with highly reduced genomes that cannot synthesise cholesterol — an essential component of their cell membranes. They must obtain cholesterol from an exogenous source in the culture medium. NYC medium contains horse plasma, which is a rich source of cholesterol and phospholipids that these organisms require for membrane assembly and growth. Modified Thayer-Martin agar uses a haemoglobin supplement and IsoVitaleX growth supplement but contains no plasma, providing no cholesterol source. Additionally, yeast autolysate in NYC medium provides nucleotides and amino acids that support Mycoplasma's limited biosynthetic capacity. The absence of these two components (horse plasma and yeast autolysate) in MTM is why it cannot support Mycoplasma or Ureaplasma growth regardless of the antibiotic composition.",{"question":120,"answer":121},"What is the role of yeast autolysate in NYC medium, and how does it reduce the CO2 requirement?","Yeast autolysate serves two functions in NYC medium. First, it provides a broad range of growth-promoting compounds — vitamins, nucleotides, amino acids, and cofactors — that reduce N. gonorrhoeae's lag phase (the delay before active growth begins), resulting in larger and more numerous colonies compared to media without yeast autolysate. Second, and more distinctively, yeast autolysate contains oxaloacetic acid. N. gonorrhoeae can metabolise oxaloacetate via decarboxylation, producing CO2 as a metabolic byproduct. This endogenous CO2 production partially satisfies the capnophilic requirement of gonococci, reducing (though not eliminating) their dependence on an external CO2 supply. In MTM, no such CO2 self-supply mechanism exists. The practical benefit is that NYC medium produces slightly better colony development in conditions where CO2 supply is inconsistent — relevant in resource-limited settings where CO2 incubators may be unavailable or unreliable.",{"question":123,"answer":124},"How are Mycoplasma hominis and Ureaplasma colonies identified on NYC medium?","Both organisms produce colonies far too small to be seen with the naked eye under normal plate reading conditions. M. hominis produces 'fried-egg' colonies: a dense, granular opaque centre with a flat, transparent peripheral zone spreading around it, typically 200–300 µm in diameter. These require a stereomicroscope or at minimum a hand lens to visualise. U. urealyticum produces even smaller colonies (15–60 µm) that appear dark brown to dark blue-grey and granular under magnification — often described as 'sea-urchin' morphology. To find these colonies on NYC medium after 2–5 days incubation, hold the plate under oblique lighting and scan the area between the visible N. gonorrhoeae colonies systematically under magnification. A useful rapid presumptive test is the urease test: U. urealyticum is strongly urease-positive — applying urease reagent to suspect colonies produces a colour change confirming ureaplasma activity.",[47],{"slug":127,"title":128,"description":129,"seoTitle":38,"seoDescription":38,"author":53,"createdDate":130,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"faq":131,"tags":132},"neisseria-gonorrhoeae-properties-disease-pathogenesis-and-laboratory-diagnosis","Neisseria gonorrhoeae: Properties, Pathogenesis, Virulence Factors, and Lab Diagnosis","Neisseria gonorrhoeae causes gonorrhoea — the second most common STI globally. Learn its Gram-negative diplococcus properties, virulence factors (pili, Opa proteins, IgA protease, LOS, PorB), diseases (urethritis, PID, ophthalmia neonatorum), lab diagnosis (Gram stain, culture, NAAT), and AMR resistance timeline.","2013-06-10",[],[47],{"slug":134,"title":135,"description":136,"seoTitle":38,"seoDescription":38,"author":53,"createdDate":137,"lastUpdatedDate":138,"draft":42,"category":43,"image":38,"faq":139,"tags":149},"fluorescent-treponemal-antibody-absorption-fta-abs-test","FTA-ABS Test: Interpretation, When It Confirms Syphilis, and FTA-ABS vs TPPA","How to interpret an FTA-ABS result: what reactive-plus-reactive-RPR confirms, why FTA-ABS stays positive for life, why it cannot monitor treatment, and how it now compares to TPPA in modern syphilis testing.","2013-06-03","2026-07-20",[140,143,146],{"question":141,"answer":142},"Why does the FTA-ABS test remain positive for life after treated syphilis, and what are the implications?","The FTA-ABS detects IgG antibodies directed specifically against Treponema pallidum antigens. Once the immune system has generated these antibodies in response to a treponemal infection, immunological memory B cells persist indefinitely and continue producing low levels of anti-treponemal IgG even after the infection has been eradicated by antibiotics. Antibiotic treatment kills the bacteria and stops the stimulus for new antibody production, but it cannot eliminate existing long-lived plasma cells or memory B cells that were generated during the infection. As a result, anti-treponemal antibody titers decline slowly but rarely reach undetectable levels — most treated patients remain FTA-ABS reactive for years to decades, and many remain positive for life. The clinical implication is that FTA-ABS cannot be used to confirm cure or active infection in a previously treated patient: a reactive FTA-ABS in someone with a history of treated syphilis five years ago simply confirms past infection. Only non-treponemal tests (RPR, VDRL) with their declining titers post-treatment can monitor treatment response and distinguish active from past infection.",{"question":144,"answer":145},"What is the significance of a beaded or atypical fluorescence pattern on FTA-ABS?","A beaded or atypical fluorescence pattern on FTA-ABS, where discrete fluorescent beads appear along the length of the treponemes rather than the uniform homogeneous fluorescence seen in true positive results, is associated with systemic lupus erythematosus (SLE). In SLE patients, auto-antibodies — particularly anti-DNA and anti-nuclear antibodies — can cross-react with treponeme antigens non-specifically, producing fluorescence that follows the outline of the organism but with an irregular, beaded appearance rather than the smooth, bright green fluorescence of a true positive. This atypical beaded pattern on FTA-ABS in a patient with known SLE or strong clinical features of autoimmune disease should be interpreted as a false positive rather than evidence of syphilis. Confirmation with an alternative treponemal test (TPHA or TPPA) and correlation with clinical findings, risk factors for syphilis, and RPR\u002FVDRL results is essential before making a syphilis diagnosis in this context.",{"question":147,"answer":148},"Why is FTA-ABS considered more sensitive than TPHA in early primary syphilis?","In the first 3–4 weeks after T. pallidum infection, the immune response is still developing and antibody concentrations are low. Both FTA-ABS and TPHA detect treponemal antibodies, but they differ in their detection mechanisms and sensitivity thresholds at this early stage. FTA-ABS uses fluorescence microscopy to directly visualise antibody coating on individual T. pallidum organisms — even small amounts of antibody produce detectable fluorescence on the treponemes. TPHA requires antibodies to agglutinate T. pallidum-sensitised red blood cells — a threshold event that requires somewhat higher antibody concentrations to produce visible agglutination. Because FTA-ABS can detect treponemal antibodies at slightly lower concentrations than TPHA, it becomes positive 1–2 weeks earlier in the primary stage, when antibodies are just beginning to appear. In established primary syphilis with a visible chancre, FTA-ABS has approximately 85–90% sensitivity compared to TPHA's 65–76% — a meaningful difference that makes FTA-ABS the preferred test when primary syphilis is strongly suspected and TPHA is negative.",[47,150],"immunofluorescence",{"slug":152,"title":153,"description":153,"seoTitle":38,"seoDescription":38,"author":53,"createdDate":137,"lastUpdatedDate":154,"draft":42,"category":43,"image":38,"faq":155,"tags":156},"venereal-disease-research-laboratory-vdrl-test","VDRL Test: Principle, Procedure, Results","2026-07-05",[],[47],[158,164,171,176,180,184,189,194,198,202],{"slug":159,"name":53,"description":160,"image":161,"body":162,"postCount":163},"acharya-tankeshwar","Editor-in-chief","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Ftankeshwar-acharya-author-microbeonline.jpg","***Tankeshwar Acharya, MSc (Medical Microbiology)***\n\n*Tankeshwar Acharya is an Assistant Professor in the Department of Microbiology at Patan Academy of Health Sciences (PAHS), Nepal, where he has been teaching and practicing clinical microbiology for over 14 years. He is the founder of Microbe Online, one of the leading free microbiology education resources on the web, covering bacteriology, mycology, parasitology, immunology, and clinical laboratory diagnostics written from direct experience in both the classroom and the diagnostic laboratory.*",432,{"slug":165,"name":166,"description":167,"image":168,"body":169,"postCount":170},"ashma-shrestha","Ashma Shrestha","SEO Copywriter and Science Communicator\nKathmandu, Nepal","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Fashma-shrestha.png","Ashma Shrestha holds a Master of Science in Medical Microbiology from the Institute of Science and Technology (IOST), Tribhuvan University, Nepal, where she developed a strong foundation in virology, molecular biology, and diagnostic microbiology.\n\nShe now works as an SEO Copywriter at Resolution Digital, where she combines her scientific training with research-driven content strategy. She is certified in Google Analytics and Google Business Profile (GBP), and brings a data-informed approach to science communication writing content that is not only accurate but structured to reach and serve the students who need it most.\n\nAt microbeonline, Ashma contributes articles primarily in virology and molecular biology, areas she finds most compelling for their mechanistic depth and their growing clinical relevance. Her writing reflects the same standard the site is built on: factual rigor, clear explanation of the *why* behind microbiology concepts, and content that helps students move from memorization to genuine understanding.\n\nShe is passionate about making complex microbiological concepts accessible without sacrificing accuracy; a skill that sits at the intersection of her scientific training and her professional work in content and SEO.",81,{"slug":172,"name":173,"description":174,"image":38,"body":38,"postCount":175},"sushmita-baniya","Sushmita Baniya","Author \u002F Contributor",32,{"slug":177,"name":178,"description":174,"image":38,"body":38,"postCount":179},"samikshya-acharya","Samikshya Acharya",20,{"slug":181,"name":182,"description":174,"image":38,"body":38,"postCount":183},"alisha-tripathi","Alisha Tripathi",6,{"slug":185,"name":186,"description":187,"image":38,"body":38,"postCount":188},"aastha-shrestha","Aastha Shrestha"," Author \u002F Contributor",10,{"slug":190,"name":191,"description":192,"image":38,"body":38,"postCount":193},"guest-author","Guest Author","Guest Author \u002F Contributor",2,{"slug":195,"name":196,"description":174,"image":38,"body":38,"postCount":197},"srijana-khanal","Srijana Khanal",18,{"slug":199,"name":200,"description":192,"image":38,"body":38,"postCount":201},"dr-poonam-acharya","Dr. Poonam Acharya",1,{"slug":203,"name":39,"description":174,"image":38,"body":204,"postCount":205},"nisha-rijal","**Nisha Rijal** is a microbiologist and quality assurance specialist. She served for nearly 12 years as a microbiologist at the National Public Health Laboratory (NPHL), Nepal's national reference laboratory, and continues to work as a consultant microbiologist in international public health organization. ",51]